Lincoln Pharmaceuticals Limited
LINCOLN.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.76B
Close$
Share Statistics
| Market cap | $12.76 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $1.80 (0.32%) |
| Earnings per Share | $43.88 |
| Beta | 0.37 |
| Outstanding Shares | 20,030,127 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 11.59 |
|---|---|
| PEG | 37.48 |
| Price to Sales | 1.61 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Lincoln Pharmaceuticals Limited
1,352 employees
CEO: Mahendrabhai Gulabdas Patel Operating from its headquarters in Ahmedabad, India, Lincoln Pharmaceuticals Ltd. is a well-established Indian enterprise dedicated to the production and commercialization of a diverse range of pharmaceutical products. The company's exte...